Sabitlenmiş Tweet
Thank you so much #UEGWeek2024, amazing opportunity to learn and share with everyone! @my_ueg @metaacademy_ofc
English
Samira Mohamad
33 posts
Samira Mohamad
@SamiraMKhalil
Medicine and research
Ciudad Autónoma de Buenos Aire Katılım Nisan 2021
87 Takip Edilen11 Takipçiler
Thanks!
Matheus Souza@mhenrique028
Thanks @JPGNonline for highlighting our work on pediatric MASLD! Children often show severe disease at dx by liver biopsy. There is an unmet need for better screening and risk stratification strategies. 🔗Link: onlinelibrary.wiley.com/doi/10.1002/jp… #livertwitter #GITwitter #MedTwitter
English
Another from our group!
JPGN@JPGNonline
📊 Meta-analysis of 35 studies (n=5898) shows pediatric #MASLD is often severe at diagnosis: MASH ~60% • Fibrosis ≥F2 ~31% • Advanced ≥F3 ~12%. Early detection & noninvasive fibrosis tools are urgently needed. 🔗 doi.org/10.1002/jpn3.7… #pediatrics #pedsgi #MASLD
English
Samira Mohamad retweetledi
🚨Happy to share our study published in @AmJGastro 📕#RedJournal!! We provide data on screen failure rates in MASH clinical trials.
journals.lww.com/ajg/abstract/9…
#LiverTwitter #LiverX #GITwitter #MedTwitter
English
Samira Mohamad retweetledi
Efficacy and Safety of Upadacitinib for Perianal Fistulizing #Crohn’s Disease: A Post Hoc Analysis of 3 Phase 3 Trials ➡️ ow.ly/vhYa50VNhxk
English
New study in Clinics and Research in Hepatology and Gastroenterology!
We evaluated the efficacy and safety of Aldafermin (FGF-19 analogue) in MASH, analyzing subgroups based on fibrosis stage and Aldafermin dosage. 💊
Link: authors.elsevier.com/c/1ksBH7sgWBrs…
English
Samira Mohamad retweetledi
🚨New study in @LiverInt!
Table 1 is more than just numbers - it sheds light on the diversity of participants in MASH clinical trials. Time to take a closer look🔍📊
🔗Link: onlinelibrary.wiley.com/doi/full/10.11…
#livertwitter #GITwitter #MedTwitter
English
Samira Mohamad retweetledi
New Review - Temido et al - Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
thelancet.com/journals/langa…
#GITwitter
English
Samira Mohamad retweetledi
"Antibiotics can accelerate colorectal cancer progression by inducing microbiota depletion"
#Cancer #MedEd #InnoTalkShow25 #medx
Top Biomedical Science@imedverse
Gut microbiota protect against colorectal tumorigenesis through lncRNA Snhg9 "Antibiotics can accelerate colorectal cancer progression by inducing microbiota depletion" cell.com/developmental-… #MedEd #medx #InnoTalkShow25 #cancer #antibiotics #GUT #microbiota
English
Samira Mohamad retweetledi
Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results for SOR102 in Ulcerative Colitis - #IBD
businesswire.com/news/home/2024…
English
Samira Mohamad retweetledi
Efficacy and safety of FGF21 analogues for metabolic dysfunction-associated steatohepatitis
In Annals of Nutrition and Metabolism
👉 pubmed.ncbi.nlm.nih.gov/39362207/
#GITwitter #MedTwitter #Feevale
@Samira67964520 @Emilysatomed
English
Samira Mohamad retweetledi
Samira Mohamad retweetledi
#SundayRead☕️
#IBD therapies & serious AE at 3yrs
🔺Biologics: ⬇️risk CV (MI, stroke), VTE, mortality vs non users
🔺Small molecules: No differce in AE vs nonusers, but ⬇️overall mortality, incl. in🔺Pt> age50 +CV risk factor
@IBDJournals @DinaAlayan doi.org/10.1093/ibd/iz…
English
Samira Mohamad retweetledi
#Frontiers24 @StMarksHospital The psychological difficulties of adolescent (11-20) w #IBD
😔Depression, anxiety
😔Isolation
😔Body image
😔Eating dis.
🚨Conséquence: ⬇️ Engagment w medical team + social life
🤝How can we engage w ado better & coping strategies #StressBucket👇🏽
English
Samira Mohamad retweetledi
🌟 Our first-ever living guideline for managing moderate-to-severe #UlcerativeColitis led by @berkeleydoc, @manasiagrawalmd, @Jhaydek, @ashwinmdibd, @FrankIScottMD, @EdwardLoftus2 prioritizes early use of advanced therapies over a step-up approach.
ow.ly/t2Ru50UahEi
English
Samira Mohamad retweetledi
Navigating Reproductive Care in Patients With Inflammatory Bowel Disease: A Comprehensive Review @PaulaCRFSousa @jp_gisbert @JulsgaardMette @maria_chs
academic.oup.com/ecco-jcc/artic…
English
Samira Mohamad retweetledi
🎯 Navigating #Reproductive Care 🤰🏻 in Patients With #Inflammatory #Bowel #Disease 🔥
✒️ @PaulaCRFSousa ✒️
📘 in @JCC_IBD 🤗
👉tinyurl.com/5e57ptrd
🟣 @Y_ECCO_IBD 🟣
⚫️ @OxUniPress ⚫️
@maria_chs 🥰
@jp_gisbert
@JulsgaardMette
@ChristianSelin3
🔴 #IBD 🤱 #GITwitter 🔴
Beatriz Gros@Bealoquebea
Navigating Reproductive Care in Patients With #IBD Fantastic review by @PaulaCRFSousa @jp_gisbert @ChristianSelin3 @JulsgaardMette @maria_chs At @JCC_IBD academic.oup.com/ecco-jcc/artic…
Brno, Czech Republic 🇨🇿 English
Samira Mohamad retweetledi
#ECCO UC Treatment Guideline Update - how it started...
@bverstockt @HolubarStefan @RajaAtreya @I_Blumenstein @AlaaEl_Hussuna @manu_barreiro @AnthonydeBuck @fgomollon @Max_Fantini @fede__furfaro @MariangelaAllo3 @PascalJuillerat @mjosecasanova @UriKopylov @EderPiotr et al.
#IBD
English
Samira Mohamad retweetledi
Seen at #UEGWeek #UEGWeek2024 this Figure on signalling pathways of JAK inhibitors for IBD
Read the Review here rdcu.be/dW00Q
English
Samira Mohamad retweetledi
